TMRW Life Sciences nets $25 mln Series B
New York City-based TMRW Life Sciences, a provider of an integrated platform for automated, software-guided embryology and cryo-management, has secured $25 million in Series B funding.
New York City-based TMRW Life Sciences, a provider of an integrated platform for automated, software-guided embryology and cryo-management, has secured $25 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination